Metaloprotease: Perbedaan antara revisi

Konten dihapus Konten ditambahkan
ESCa (bicara | kontrib)
ESCa (bicara | kontrib)
Baris 21:
| accessdate = 2010-12-04
| work = Department of Anatomy, University of California at San Francisco; Egeblad M, Werb Z.
}}</ref> pada [[kanker payudara]], [[kanker usus besar|usus besar]], dan [[kanker pankreas|pankreas]],<ref>{{en}}{{cite web
| url = http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639045
| title = Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2
| accessdate = 2010-12-07
| work = Department of Pharmacology and Cancer Biology, Department of Medicine, Duke University; Kelly J. Gordon, Kellye C. Kirkbride, Tam How, dan Gerard C. Blobe
| quote = MMPs have been implicated in facilitating the invasion and metastasis of breast, colon and pancreatic cancers
}}</ref> dan telah sering menjadi target terapi anti kanker,<ref>{{en}}{{cite web
| url = http://www.ncbi.nlm.nih.gov/pubmed/11923519
Baris 26 ⟶ 32:
| accessdate = 2010-12-04
| work = Department of Pathology and Cancer Research Institute, University of California; Coussens LM, Fingleton B, Matrisian LM.
}}</ref> oleh karena selaluekspresinya terjadi ekspresiyang berlebih pada tumor/kanker.<ref>{{en}}{{cite web
| url = http://www.ncbi.nlm.nih.gov/pubmed/12908552
| title = Matrix metalloproteinases and tumor progression.